STEPHENSON BRIAN C (CIK 1780030) reported 30 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-01). Recent activity: Buy FTH (831 shares), Buy FTH (1,910 shares), Buy FTH (1,638 shares), Buy FTH (4,255 shares), Buy FTH (4,400 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 831 | $19,396 |
| 2026-07-01 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 1,910 | $43,834 |
| 2026-07-01 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 1,638 | $39,115 |
| 2026-07-01 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 4,255 | $106,290 |
| 2026-07-01 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 4,400 | $102,960 |
| 2026-07-01 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 600 | $14,532 |
| 2026-06-26 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 1,358 | $34,697 |
| 2026-06-26 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 3,000 | $77,940 |
| 2026-06-26 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 3,400 | $91,732 |
| 2026-06-26 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 100 | $2,777 |
| 2026-06-26 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 580 | $13,694 |
| 2026-06-26 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 4,212 | $104,879 |
| 2026-06-26 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 2,891 | $72,911 |
| 2026-06-26 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 100 | $2,639 |
| 2026-06-24 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 1,797 | $36,353 |
| 2026-06-24 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 1,118 | $23,277 |
| 2026-06-24 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 1,583 | $35,459 |
| 2026-06-24 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 3,329 | $77,499 |
| 2026-06-24 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 356 | $8,526 |
| 2026-06-24 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 6,836 | $164,884 |
| 2026-06-24 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 1,969 | $48,910 |
| 2026-06-24 | Faeth Therapeutics, Inc. (FTH) | Chief Financial Officer | Buy | 425 | $11,012 |
| 2025-02-27 | BridgeBio Pharma, Inc. (BBIO) | CFO and Treasurer | Buy | 8,500 | $144,500 |
| 2025-02-27 | BridgeBio Pharma, Inc. (BBIO) | CFO and Treasurer | Sell | 8,400 | $278,712 |
| 2025-02-27 | BridgeBio Pharma, Inc. (BBIO) | CFO and Treasurer | Sell | 100 | $3,418 |
Source: SEC Form 4 filings · as of 2026-07-01